News

Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last
Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.
Lawsuit alleges Maryland man with diabetes became blind after taking Ozempic
A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...
Say goodbye to cheap versions of Ozempic and Wegovy
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
Novo Nordisk: Examining Tariff And Pricing Risks
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
US Man Becomes Blind After Taking Ozempic Due to a Rare Eye Condition
An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.
Health and Me on MSN18h
US Man Became Blind After Consuming Ozempic: Do Weight Loss Drugs Cause Blindness?
Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...
pharmaphorum21h
Novo Nordisk will file semaglutide for MASH next year
Novo Nordisk's GLP-1 receptor agonist semaglutide ... which is already seeing sales rocket on the back of its use as Ozempic for diabetes, Wegovy for obesity, and label extensions for both brands ...